MedPath

A Proof Of Concept Study to Investigate the Clinical, Histological And Molecular Predictors of Response to Oral and Intranasal Corticosteroid in Nasal Polyposis - Prednisolone Inductio

Phase 1
Conditions
asal Polyposis
Registration Number
EUCTR2004-001474-12-GB
Lead Sponsor
Research and Innovation Services
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

Male or Female Participants 16-75, with bilateral nasal polyposis of grade 2-3.
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Patients who have used oral or nasule steroids within the preceding 3 months.
Pregnant or breastfeeding mothers, or those taking inadequate contraceptive measures.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath